CAPPED BONUSZERTIFIKAT - MERCK & CO. Share Price

Certificat

DE000PC67M13

Market Closed - Börse Stuttgart 08:54:02 17/05/2024 BST
125.7 EUR -0.08% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month-0.78%
1 month+0.65%
Date Price Change
17/05/24 125.7 -0.08%
16/05/24 125.8 +0.05%
15/05/24 125.7 -0.37%
14/05/24 126.2 -0.18%
13/05/24 126.4 +0.10%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 08:54 am

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC67M1
ISINDE000PC67M13
Date issued 25/03/2024
Strike 140 $
Maturity 20/09/2024 (124 Days)
Parity 1 : 1
Emission price 119.6
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 126.7
Lowest since issue 121.5
Spread 0.02
Spread %0.02%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.2 USD
Average target price
141.6 USD
Spread / Average Target
+7.96%
Consensus